JACKLYN SLOVER: Open Payments
NPI 1750058434 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 19 payments from 9 companies in 2025. Trend: 2023 $792 · 2024 $471 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
| BIOTRONIK INC. | 1 | $65 |
| PFIZER INC. | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: LEQVIO, Kerendia, JARDIANCE, AMVIA EDGE, ELIQUIS, VERQUVO, LifeVest, Wegovy.
Industry payments across IN — which companies pay providers there.
